• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Approved Drugs

Rozebalamin/Methylcobalamin

Riluzole/Tiglutik

Radicava/Edaravone

Nuedexta

Tofersen/Qalsody

Primary Sidebar

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Liam Dwyer, England

    Liam Dwyer, England

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Mike Cels, Canada

    Mike Cels, Canada

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Jack Buzby, USA

    Jack Buzby, USA

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Hollister

    Hollister
    hollister

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Zabun Nassar, England

    Zabun Nassar, England

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • John Dinon, Australia

    John Dinon, Australia

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Mark Miller, UK

    Mark Miller, UK

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Ian Gale, Australia

    Ian Gale, Australia

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

  • Michael Lee, Australia

    Michael Lee, Australia

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login